减充血剂市场：按类型、类别、适应症、分销管道划分 – 2025-2030 年全球预测

2023年减充血剂市场价值为66.3亿美元，预计到2024年将达到70.3亿美元，复合年增长率为6.22%，到2030年将达到101.3亿美元。

减充血剂是一种常用于缓解上呼吸道鼻塞的药物，这种鼻塞可能由多种疾病引起，包括感冒、过敏和鼻窦炎。它的作用是收缩血管、减少肿胀和改善气流。由于呼吸道疾病普遍存在，而季节性变化和污染水平上升又加剧了呼吸道疾病，因此对减充血剂的需求仍然很高。它适用于非处方药和处方药，并吸引广泛的最终用途，包括个人消费者、医疗保健提供者和製药公司。影响减充血剂市场的关键成长要素包括全球过敏和呼吸道疾病盛行率的上升，以及消费者对缓解症状的意识和偏好的提高。最近的创新包括非困倦配方和可提供持久缓解的缓释性产品。此外，成长机会包括促进获取这些药物的数位健康平台的扩展、远端医疗的成长以及草药减充血剂的日益接受，这反映了消费者对天然成分不断变化的偏好。挑战包括有关配方和副作用的严格监管要求，以及滴鼻剂和生理食盐水等替代疗法的竞争。市场成长可能会受到血压升高和失眠等潜在副作用的阻碍，这可能会导致消费者信心下降。可以探索创新机会，开发更有针对性的递送系统，提高疗效，同时最大限度地减少副作用。此外，投资研究以了解个人对减充血剂反应的遗传基础可能会导致个人化医疗的方法。鑑于这些动态，市场竞争激烈，公司需要透过持续创新来脱颖而出，确保遵守监管标准，并利用数位健康的进步来吸引消费者，还有很大的空间来加强和拓展尚未开发的区域市场。

市场动态：揭示快速发展的减充血剂市场的关键市场洞察

供需的动态交互作用正在改变减充血剂市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

• 市场驱动因素
  • 过敏和呼吸道疾病的盛行率增加
  • 自我治疗和减充血剂商业化的趋势
• 市场限制因素
  • 过度使用减充血剂可能产生的副作用以及替代疗法的可用性
• 市场机会
  • 加强对新减充血剂配方的调查和核准
  • 加强对安全有效使用减充血剂的认知宣传活动
• 市场挑战
  • 对减充血剂的核准、销售和分销有严格的规定

波特的五力：驾驭减充血剂市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解减充血剂市场的外部影响

外部宏观环境因素在塑造减充血剂市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解减充血剂市场的竞争格局

减充血剂市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵供应商在减充血剂市场的绩效评估

FPNV 定位矩阵是评估减充血剂市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製减充血剂市场的成功之路

减充血剂市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 过敏和呼吸道疾病的发生率增加
    • 自我治疗趋势和非处方减充血剂的可用性
  • 抑制因素
    • 过度使用减充血剂可能产生的副作用以及替代疗法的可用性
  • 机会
    • 加强对新减充血剂配方的调查和核准
    • 加强对安全有效使用减充血剂的认知宣传活动
  • 任务
    • 对减充血剂的核准、销售和分销有严格的规定
• 市场区隔分析
  • 类型：液体或糖浆由于易于使用和剂量灵活性而具有很高的采用率。
  • 分销管道：网路药局因其便利性和广泛的产品选择而变得越来越受欢迎。
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章减充血剂市场：依类型

• 降低
• 调味粉
• 液体/糖浆
• 鼻喷剂
• 锭剂/胶囊

第七章减充血剂市场：依类别

• 鼻减充血剂
• 口服减充血剂
• 流行的减充血剂

第八章减充血剂市场：依适应症分类

• 过敏
• 寒冷的
• 花粉症
• 鼻炎
• 鼻窦炎

第九章减充血剂市场：依通路

• 医院药房
• 网路药房
• 零售药房

第10章美洲减充血剂市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第十一章亚太减充血剂市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十二章欧洲、中东和非洲减充血剂市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十三章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
  • Aurobindo Pharma 鼻喷剂获得美国FDA核准
  • Acmus Drugs & Pharmaceuticals 推出新型鼻喷剂
  • Haleon 的 Otrivin Nasal Mist 简介，一种创新的鼻减充血产品
• 战略分析和建议

公司名单

• Alcon
• Aptar Pharma
• AstraZeneca PLC
• Aurobindo Pharma Limited
• Bausch Health Companies Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH
• Church & Dwight Co., Inc.
• Cipla Ltd.
• Dr. Reddy's Laboratories Limited
• Eli Lilly and Company
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Limited
• Haleon Group of Companies
• Johnson & Johnson Services, Inc.
• Perrigo Company PLC
• Procter & Gamble Company
• Reckitt Benckiser Group PLC
• Sanofi SA
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.
• The Boots Company PLC
• Viatris, Inc.
• Walgreen Co.

The Decongestant Market was valued at USD 6.63 billion in 2023, expected to reach USD 7.03 billion in 2024, and is projected to grow at a CAGR of 6.22%, to USD 10.13 billion by 2030.

Decongestants are a class of medication commonly used to relieve nasal congestion in the upper respiratory tract, which can occur due to a variety of conditions such as colds, allergies, and sinusitis. They function by contracting blood vessels, reducing swelling, and allowing easier airflow. The necessity for decongestants remains high due to the prevalence of these respiratory issues, exacerbated by seasonal changes and increasing pollution levels. They are applied in both over-the-counter and prescription medications, appealing to a broad end-use scope that includes individual consumers, healthcare providers, and pharmaceutical companies. Key growth factors influencing the decongestant market include the rising global incidence of allergies and respiratory ailments, coupled with heightened consumer awareness and preference for symptomatic relief. Recent innovations comprise non-drowsy formulations and extended-release products that provide prolonged relief. Furthermore, opportunities lie in the expansion of digital health platforms that can facilitate easier access to these medications, telemedicine growth, and an increasing acceptance of herbal decongestants, reflecting evolving consumer preferences toward natural ingredients. Challenges include stringent regulatory requirements regarding drug formulations and side effects, as well as competition from alternative therapies such as nasal sprays and saline solutions. Market growth can be impeded by potential side effects such as increased blood pressure and insomnia, which may lead to reduced consumer trust. Innovation opportunities could be explored in developing more targeted delivery systems that enhance efficacy while minimizing side effects. Furthermore, investment in research directed at understanding the genetic basis of individual responses to decongestants could lead to personalized medicine approaches. Given these dynamics, the market can be characterized as competitive, with significant scope for companies to differentiate themselves through ongoing innovation, ensuring compliance with regulatory standards, and capitalizing on digital health advancements for enhanced consumer engagement and expansion into unexplored geographic markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Decongestant Market

The Decongestant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of allergic conditions and respiratory disorders
  • Trend toward self-medication and over-the-counter availability of decongestant
• Market Restraints
  • Possible side effects from overuse of decongestants and availability of alternative therapies
• Market Opportunities
  • Increasing research and approvals for new decongestant formulations
  • Growing number of awareness campaigns about the safe and effective use of decongestants
• Market Challenges
  • Stringent regulations governing the approval, sale, and distribution of decongestants

Porter's Five Forces: A Strategic Tool for Navigating the Decongestant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Decongestant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Decongestant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Decongestant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Decongestant Market

A detailed market share analysis in the Decongestant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Decongestant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Decongestant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Decongestant Market

A strategic analysis of the Decongestant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Decongestant Market, highlighting leading vendors and their innovative profiles. These include Alcon, Aptar Pharma, AstraZeneca PLC, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Church & Dwight Co., Inc., Cipla Ltd., Dr. Reddy's Laboratories Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Haleon Group of Companies, Johnson & Johnson Services, Inc., Perrigo Company PLC, Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., The Boots Company PLC, Viatris, Inc., and Walgreen Co..

Market Segmentation & Coverage

This research report categorizes the Decongestant Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Drops, Flavoured Powders, Liquids/Syrups, Nasal Sprays, and Tablets/Capsules.
• Based on Category, market is studied across Nasal Decongestant, Oral Decongestant, and Topical Decongestant.
• Based on Indication, market is studied across Allergies, Cold, Hay Fever, Rhinitis, and Sinusitis.
• Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of allergic conditions and respiratory disorders
    • 5.1.1.2. Trend toward self-medication and over-the-counter availability of decongestant
  • 5.1.2. Restraints
    • 5.1.2.1. Possible side effects from overuse of decongestants and availability of alternative therapies
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing research and approvals for new decongestant formulations
    • 5.1.3.2. Growing number of awareness campaigns about the safe and effective use of decongestants
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations governing the approval, sale, and distribution of decongestants
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Higher adoption of liquids or syrups for their ease of use and dosage flexibility make
  • 5.2.2. Distribution Channel: Growing preferences for online pharmacies owing to their convenience and wide product availability
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Decongestant Market, by Type

• 6.1. Introduction
• 6.2. Drops
• 6.3. Flavoured Powders
• 6.4. Liquids/Syrups
• 6.5. Nasal Sprays
• 6.6. Tablets/Capsules

7. Decongestant Market, by Category

• 7.1. Introduction
• 7.2. Nasal Decongestant
• 7.3. Oral Decongestant
• 7.4. Topical Decongestant

8. Decongestant Market, by Indication

• 8.1. Introduction
• 8.2. Allergies
• 8.3. Cold
• 8.4. Hay Fever
• 8.5. Rhinitis
• 8.6. Sinusitis

9. Decongestant Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospital Pharmacies
• 9.3. Online Pharmacies
• 9.4. Retail Pharmacies

10. Americas Decongestant Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Decongestant Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Decongestant Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Aurobindo Pharma Secures US FDA Approval for Nasal Spray
  • 13.3.2. Akums Drugs and Pharmaceuticals Unveils New Nasal Spray
  • 13.3.3. Introduction of Otrivin Nasal Mist by Haleon, an Innovative Product in Nasal Decongestion
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alcon
• 2. Aptar Pharma
• 3. AstraZeneca PLC
• 4. Aurobindo Pharma Limited
• 5. Bausch Health Companies Inc.
• 6. Bayer AG
• 7. Boehringer Ingelheim International GmbH
• 8. Church & Dwight Co., Inc.
• 9. Cipla Ltd.
• 10. Dr. Reddy's Laboratories Limited
• 11. Eli Lilly and Company
• 12. GlaxoSmithKline PLC
• 13. Glenmark Pharmaceuticals Limited
• 14. Haleon Group of Companies
• 15. Johnson & Johnson Services, Inc.
• 16. Perrigo Company PLC
• 17. Procter & Gamble Company
• 18. Reckitt Benckiser Group PLC
• 19. Sanofi S.A.
• 20. Sun Pharmaceutical Industries Limited
• 21. Teva Pharmaceutical Industries Ltd.
• 22. The Boots Company PLC
• 23. Viatris, Inc.
• 24. Walgreen Co.

LIST OF FIGURES

• FIGURE 1. DECONGESTANT MARKET RESEARCH PROCESS
• FIGURE 2. DECONGESTANT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DECONGESTANT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DECONGESTANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DECONGESTANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DECONGESTANT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DECONGESTANT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DECONGESTANT MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DECONGESTANT MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DECONGESTANT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DECONGESTANT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS DECONGESTANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS DECONGESTANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES DECONGESTANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES DECONGESTANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC DECONGESTANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC DECONGESTANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. DECONGESTANT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. DECONGESTANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DECONGESTANT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DECONGESTANT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DECONGESTANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DECONGESTANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DECONGESTANT MARKET DYNAMICS
• TABLE 7. GLOBAL DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DECONGESTANT MARKET SIZE, BY DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DECONGESTANT MARKET SIZE, BY FLAVOURED POWDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DECONGESTANT MARKET SIZE, BY LIQUIDS/SYRUPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DECONGESTANT MARKET SIZE, BY TABLETS/CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DECONGESTANT MARKET SIZE, BY NASAL DECONGESTANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DECONGESTANT MARKET SIZE, BY ORAL DECONGESTANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DECONGESTANT MARKET SIZE, BY TOPICAL DECONGESTANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DECONGESTANT MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DECONGESTANT MARKET SIZE, BY COLD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DECONGESTANT MARKET SIZE, BY HAY FEVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DECONGESTANT MARKET SIZE, BY RHINITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DECONGESTANT MARKET SIZE, BY SINUSITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS DECONGESTANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. CANADA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 42. CANADA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES DECONGESTANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC DECONGESTANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. CHINA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. CHINA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 64. CHINA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. CHINA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. INDIA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDIA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 68. INDIA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDIA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. ITALY DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ITALY DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 137. ITALY DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. ITALY DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. POLAND DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. POLAND DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 153. POLAND DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. POLAND DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 155. QATAR DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. QATAR DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 157. QATAR DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 158. QATAR DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 195. DECONGESTANT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. DECONGESTANT MARKET, FPNV POSITIONING MATRIX, 2023